Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
With a $2.9 million NIH grant, Rochester researchers will study a group of heart muscle disorders that account for up to 20 percent of cases of sudden death in young people.
2/5/2014 | 1 comment
With more than 100,000 patients a year coming to the emergency room at UR Medicine’s Strong Memorial Hospital, it’s a valuable piece of real estate for investigators seeking to enroll patients in their research studies.
2/4/2014 | 0 comments
According to a new study in the American Psychological Association’s Journal of Health Psychology, in some cases, the answer is yes.
2/3/2014 | 1 comment
Astrocytes – cells that until only recently have been dismissed as merely brain “glue” – are becoming increasingly important and flexible tools in confronting a range of neurological disorders. New research shows that the right kind of astrocyte can restore order and rescue cells in brains ravaged by Parkinson’s disease.
1/29/2014 | 2 comments
When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.
1/28/2014 | 0 comments